Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01925963 · ClinicalTrials.gov registry record
Normative Datasets for Assessments Planned for Mild Traumatic Brain Injury (NORMAL)
A clinical trial of Focus: Healthy Adults Without Brain Injury, sponsored by Lindell Weaver.
- Completed
- Registry status
- 83
- Enrollment target
- 2
- Study locations
NCT01925963: Completed study of Focus: Healthy Adults Without Brain Injury, sponsored by Lindell Weaver.
NCT01925963 is a study of Focus: Healthy Adults Without Brain Injury that has completed, run by Lindell Weaver. The registered enrollment target is 83 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01925963, a study of Focus: Healthy Adults Without Brain Injury, has completed, sponsored by Lindell Weaver.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the research study is to collect information about brain function and structure among active duty military personnel or civilians who are healthy. Researchers want to develop a database from normal volunteers that will be used in comparison with a similar database from active duty military with post-concussive syndrome (PCS) from a mild traumatic brain injury. Findings from this study may be used to design larger studies that will evaluate whether hyperbaric oxygen treatments actually improve PCS. Participants in this study will undergo numerous tests to assess physical, mental, and intellectual health and how they might change over time. Participants will wear heart and activity monitors, undergo brain imaging, provide blood and urine for laboratory testing, and have vision, hearing, balance, and muscle function tests. They will also complete a number of questionnaires and interviews. This battery of tests will be repeated twice more over the course of 6 months.
Conditions Studied
Study Locations (2)
Colorado
- Outcomes Assessment Center - Colorado Springs
- Evans Army Community Hospital - Colorado Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2014-01-10 |
| Est. Completion | 2016-01-06 |
What the finished NCT01925963 record still lists
NCT01925963 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 1 condition, with Focus: Healthy Adults Without Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT01925963 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01925963 about?
NCT01925963 is a clinical study titled "Normative Datasets for Assessments Planned for Mild Traumatic Brain Injury (NORMAL)". The purpose of the research study is to collect information about brain function and structure among active duty military personnel or civilians who are healthy. Researchers want to develop a database from normal volunteers that will be used in comparison with a similar database from active duty mil...
What is the current status of trial NCT01925963?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2014-01-10. Estimated completion is 2016-01-06.
What conditions does trial NCT01925963 study?
This clinical trial studies the following conditions: Focus: Healthy Adults Without Brain Injury.
Who is sponsoring clinical trial NCT01925963?
This trial is sponsored by Lindell Weaver, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01925963 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI